The effect of self-monitoring of blood pressure on medication adherence and lifestyle factors: A systematic review and meta-analysis

American Journal of Hypertension

Volumn 28, Issue 10, 2015, Pages 1209-1221

  Fletcher, Benjamin R ^a   Hartmann Boyce, Jaime ^a   Hinton, Lisa ^a   Mcmanus, Richard J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

adherence; blood pressure; hypertension; meta analysis; non pharmacologic; self monitoring

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ARTICLE; BEHAVIOR CHANGE; BLOOD PRESSURE MONITORING; DIASTOLIC BLOOD PRESSURE; FOLLOW UP; HUMAN; HYPERTENSION; LIFESTYLE; MEDICATION COMPLIANCE; META ANALYSIS; PATIENT COMPLIANCE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; SELF MONITORING; SELF MONITORING OF BLOOD PRESSURE; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE; BLOOD PRESSURE; DIET; EXERCISE; SELF CARE;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; DIET; EXERCISE; HUMANS; HYPERTENSION; LIFE STYLE; MEDICATION ADHERENCE; SELF CARE;

EID: 84942832199     PISSN: 08957061     EISSN: 19417225     Source Type: Journal    
DOI: 10.1093/ajh/hpv008     Document Type: Article

References (47)

1. Bray EP, Holder R, Mant J, McManus RJ. Does self-monitoring reduce blood pressure?. Meta-Analysis with meta-regression of randomized controlled trials. Ann Med 2010; 42:371-386.
2. Stergiou GS, Bliziotis IA. Home blood pressure monitoring in the diagnosis and treatment of hypertension: a systematic review. Am J Hypertens 2011; 24:123-134.
3. Uhlig K, Patel K, Ip S, Kitsios GD, Balk EM. Self-measured blood pressure monitoring in the management of hypertension: a systematic review and meta-Analysis. Ann Intern Med 2013; 159:185-194.
4. Fischer M, Stedman M, Lii J, Vogeli C, Shrank W, Brookhart MA, Weissman J. Primary medication non-Adherence: analysis of 195, 930 electronic prescriptions. J Gen Intern Med 2010; 25:284-290.
5. Gwadry-Sridhar FH, Manias E, Lal L, Salas M, Hughes DA, Ratzki-Leewing A, Grubisic M. Impact of interventions on medication adherence and blood pressure control in patients with essential hypertension: a systematic review by the ISPOR medication adherence and persistence special interest group. Value Health 2013; 16:863-871.
6. Hedayati SS, Elsayed EF, Reilly RF. Non-pharmacological aspects of blood pressure management: what are the data?. Kidney Int 2011; 79:1061-1070.
7. Ogedegbe G, Schoenthaler A. A systematic review of the effects of home blood pressure monitoring on medication adherence. J Clin Hypertens 2006; 8:174-180.
8. Abdullah A, Othman S. The influence of self-owned home blood pressure monitoring (HBPM) on primary care patients with hypertension: a qualitative study. BMC Fam Pract 2011; 12:143.
9. Saito I, Nomura M, Hirose H, Kawabe H. Use of home blood pressure monitoring and exercise, diet and medication compliance in Japan. Clin Exp Hypertens 2010; 32:210-213.
10. McManus RJ, Wilson S, Delaney BC, Fitzmaurice DA, Hyde CJ, Tobias RS, Jowett S, Hobbs FD. Review of the usefulness of contacting other experts when conducting a literature search for systematic reviews. BMJ 1998; 317:1562-1563.
11. Fletcher B, Hartmann-Boyce J, Roberts N, Hinton L, McManus RJ. Effect of home blood pressure monitoring on medication adherence, medication persistence and lifestyle factors in hypertensives: systematic review protocol, http://www.crd.york.ac.uk/PROSPERO/display-record.asp?. ID=CRD42014007567, 2014.
12. Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions [Version 5.0.2] The Cochrane Collaboration. www. cochrane-handbook.org, 2009.
13. Bailey B, Carney SL, Gillies AA, Smith AJ. Antihypertensive drug treatment: a comparison of usual care with self blood pressure measurement. J Hum Hypertens 1999; 13:147-150.
14. Bove AA, Homko CJ, Santamore WP, Kashem M, Kerper M, Elliott DJ. Managing hypertension in urban underserved subjects using telemedicine-A clinical trial. Am Heart J 2013; 165:615-621.
15. De Souza WKSB, Jardim PCBV, Brito LP, Araujo FA, Sousa ALL. Self measurement of blood pressure for control of blood pressure levels and adherence to treatment. Arquivos Brasileiros de Cardiologia 2012; 98:167-174.
16. Düsing R, Handrock R, Klebs S, Tousset E, Vrijens B. Impact of supportive measures on drug adherence in patients with essential hypertension treated with valsartan: the randomized, open-label, parallel group study VALIDATE. J Hypertens 2009; 27:894-901.
17. Fikri-Benbrahim N, Faus MJ, Martínez-Martínez F, Sabater-Hernandez D. Impact of a community pharmacists' hypertension-care service on medication adherence. The AFenPA study. Res Social Adm Pharm 2013; 9:797-805.
18. Friedman RH, Kazis LE, Jette A, Smith MB, Stollerman J, Torgerson J, Carey K. A telecommunications system for monitoring and counseling patients with hypertension. Impact on medication adherence and blood pressure control. Am J Hypertens 1996; 9:285-292.
19. Green BB, Anderson ML, Cook AJ, Catz S, Fishman PA, McClure JB, Reid RJ. e-Care for heart wellness: a feasibility trial to decrease blood pressure and cardiovascular risk. Am J Prev Med 2014; 46:368-377.
20. Haynes RB, Sackett DL, Gibson ES, Taylor DW, Hackett BC, Roberts RS, Johnson AL. Improvement of medication compliance in uncontrolled hypertension. http://onlinelibrary.wiley.com/o/cochrane/clcentral/ articles/229/CN-00017229/frame.html 1976.
21. Hosseininasab M, Jahangard-Rafsanjani Z, Mohagheghi A, Sarayani A, Rashidian A, Javadi M, Ahmadvand A, Hadjibabaie M, Gholami K. Self-monitoring of blood pressure for improving adherence to antihypertensive medicines and blood pressure control: a randomized controlled trial. Am J Hypertens 2014; 27:1339-1345.
22. Johnson AL, Taylor DW, Sackett DL, Dunnett CD, Shimizu AG. Selfrecording of blood pressure in the management of hypertension. Can Med Assoc J 1978; 119:1034-1039.
23. Kirscht JP, Kirscht JL, Rosenstock IM. A test of interventions to increase adherence to hypertensive medical regimens. http://onlinelibrary.wiley. com/o/cochrane/clcentral/articles/277/CN-00027277/frame.html 1981.
24. Magid DJ, Ho PM, Olson KL, Brand DW, Welch LK, Snow KE, Lambert-Kerzner AC, Plomondon ME, Havranek EP. A multimodal blood pressure control intervention in 3 healthcare systems. Am J Manag Care 2011; 17:e96-103.
25. Marquez-Contreras E, Martell-Claros N, Gil-Guillen V, de la Figuera-Von Wichmann M, Casado-Martínez JJ, Martin-de Pablos JL, Figueras M, Galera J, Serra A; Compliance Group of the Spanish Society of Hypertension (SEE). Efficacy of a home blood pressure monitoring programme on therapeutic compliance in hypertension: the EAPACUMHTA study. J Hypertens 2006; 24:169-175.
26. McKenney JM, Munroe WP, Wright Jr. JT. Impact of an electronic medication compliance aid on long-Term blood pressure control. J Clin Pharmacol 1992; 32:277-283.
27. McManus RJ, Mant J, Roalfe A, Oakes RA, Bryan S, Pattison HM, Hobbs FD. Targets and self monitoring in hypertension: randomised controlled trial and cost effectiveness analysis. BMJ 2005; 331:22.
28. Mehos BM, Saseen JJ, MacLaughlin EJ. Effect of pharmacist intervention and initiation of home blood pressure monitoring in patients with uncontrolled hypertension. Pharmacotherapy 2000; 20:1384-1389.
29. Midanik LT, Resnick B, Hurley LB, Smith EJ, McCarthy M. Home blood pressure monitoring for mild hypertensives. Public Health Rep 1991; 106:85-89.
30. Migneault JP, Dedier JJ, Wright JA, Heeren T, Campbell MK, Morisky DE, Rudd P, Friedman RH. A culturally adapted telecommunication system to improve physical activity, diet quality, and medication adherence among hypertensive African-Americans: a randomized controlled trial. Ann Behav Med 2012; 43:62-73.
31. Niiranen TJ, Leino K, Puukka P, Kantola I, Karanko H, Jula AM. Lack of impact of a comprehensive intervention on hypertension in the primary care setting. Am J Hypertens 2014; 27:489-496.
32. Ogbuokiri JE. Self-monitoring of blood pressures in hypertensive subjects and its effects on patient compliance. Drug Intell Clin Pharm 1980; 14:424-427.
33. Ogedegbe G, Tobin JN, Fernandez S, Cassells A, Diaz-Gloster M, Khalida C, Pickering T, Schwartz J. Counseling African Americans to Control Hypertension: cluster-randomized clinical trial main effects. Circulation 2014; 129:2044-2051.
34. Rinfret S, Lussier MT, Peirce A, Duhamel F, Cossette S, Lalonde L, Tremblay C, Guertin MC, LeLorier J, Turgeon J, Hamet P; LOYAL Study Investigators. The impact of a multidisciplinary information technology-supported program on blood pressure control in primary care. Circ Cardiovasc Qual Outcomes 2009; 2:170-177.
35. Rudd P, Miller NH, Kaufman J, Kraemer HC, Bandura A, Greenwald G, Debusk RF. Nurse management for hypertension. A systems approach. Am J Hypertens 2004; 17:921-927.
36. Stewart K, Mc Namara KP, George J. Challenges in measuring medication adherence: experiences from a controlled trial. Int J Clin Pharm 2014; 36:15-19.
37. van Onzenoort HA, Verberk WJ, Kroon AA, Kessels AG, Nelemans PJ, van der Kuy PH, Neef C, de Leeuw PW. Effect of self-measurement of blood pressure on adherence to treatment in patients with mild-Tomoderate hypertension. J Hypertens 2010; 28:622-627.
38. Vrijens B, Goetghebeur E. Comparing compliance patterns between randomized treatments. Control Clin Trials 1997; 18:187-203.
39. Wakefield BJ, Holman JE, Ray A, Scherubel M, Adams MR, Hills SL, Rosenthal GE. Outcomes of a home telehealth intervention for patients with diabetes and hypertension. Telemed J E Health 2012; 18:575-579.
40. Zarnke KB, Feagan BG, Mahon JL, Feldman RD. A randomized study comparing a patient-directed hypertension management strategy with usual office-based care. Am J Hypertens 1997; 10:58-67.
41. Cohen J (ed). Statistical Power Analysis for the Behavioral Sciences, 2nd edn. Hillsdale, NJ: Lawrence Erlbaum Associates, 1988.
42. Chowdhury R, Khan H, Heydon E, Shroufi A, Fahimi S, Moore C, Stricker B, Mendis S, Hofman A, Mant J, Franco OH. Adherence to cardiovascular therapy: a meta-Analysis of prevalence and clinical consequences. Eur Heart J 2013; 34:2940-2948.
43. Mennini FS, Marcellusi A, von der Schulenburg JM, Gray A, Levy P, Sciattella P, Soro M, Staffiero G, Zeidler J, Maggioni A, Schmieder RE. Cost of poor adherence to anti-hypertensive therapy in five European countries. Eur J Health Econ 2014; 5:5.
44. Nasseh K, Glave Frazee S, Visaria J, Vlahiotis A, Tian Y. Cost of medication nonadherence associated with diabetes, hypertension, and dyslipidemia. Am J Pharm Benefits 2012; 4:e41-e47.
45. Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-Analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ 2009; 338:b1665.
46. Takiya LN, Peterson AM, Finley RS. Meta-Analysis of interventions for medication adherence to antihypertensives. Ann Pharmacother 2004; 38:1617-1624.
47. Peterson AM, Takiya L, Finley R. Meta-Analysis of trials of interventions to improve medication adherence. Am J Health Syst Pharm 2003; 60:657-665.